Terms: = Melanoma AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
1973 results:
1. Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as melanoma and Lung Cancer.
Maietta I; Viscusi E; Laudati S; Iannaci G; D'Antonio A; Melillo RM; Motti ML; De Falco V
Cells; 2024 Sep; 13(18):. PubMed ID: 39329730
[TBL] [Abstract] [Full Text] [Related]
2. Design, Synthesis, and Anticancer and Antibacterial Activities of Quinoline-5-Sulfonamides.
Zieba A; Pindjakova D; Latocha M; Plonka-Czerw J; Kusmierz D; Cizek A; Jampilek J
Molecules; 2024 Aug; 29(17):. PubMed ID: 39274892
[TBL] [Abstract] [Full Text] [Related]
3. Long-Read MDM4 Sequencing Reveals Aberrant Isoform Landscape in Metastatic melanomas.
Patrick N; Markey M
Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273363
[TBL] [Abstract] [Full Text] [Related]
4. A novel approach to the analysis of Overall Survival (OS) as response with Progression-Free Interval (PFI) as condition based on the RNA-seq expression data in The Cancer Genome Atlas (TCGA).
Lin B; Wang K; Yuan Y; Wang Y; Liu Q; Wang Y; Sun J; Wang W; Wang H; Zhou S; Jin K; Zhang M; Lai Y
BMC Bioinformatics; 2024 Sep; 25(1):300. PubMed ID: 39271985
[TBL] [Abstract] [Full Text] [Related]
5. Inverse correlation between tp53 gene status and PD-L1 protein levels in a melanoma cell model depends on an IRF1/SOX10 regulatory axis.
Martinkova L; Zatloukalova P; Kucerikova M; Friedlova N; Tylichova Z; Zavadil-Kokas F; Hupp TR; Coates PJ; Vojtesek B
Cell Mol Biol Lett; 2024 Sep; 29(1):117. PubMed ID: 39237877
[TBL] [Abstract] [Full Text] [Related]
6. BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.
Prosdocimi E; Carpanese V; Todesca LM; Varanita T; Bachmann M; Festa M; Bonesso D; Perez-Verdaguer M; Carrer A; Velle A; Peruzzo R; Muccioli S; Doni D; Leanza L; Costantini P; Stein F; Rettel M; Felipe A; Edwards MJ; Gulbins E; Cendron L; Romualdi C; Checchetto V; Szabo I
Sci Adv; 2024 Sep; 10(36):eadn9361. PubMed ID: 39231216
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of Pan-RAF Inhibitor LY3009120 on Human Uveal melanoma Cell Line 92-1.
Gao YU; Wendt S; Krohn S; Alammar M; Junghanss C; Nolte I; Escobar HM
Anticancer Res; 2024 Sep; 44(9):3843-3848. PubMed ID: 39197916
[TBL] [Abstract] [Full Text] [Related]
8. Challenges in Diagnosing Metastatic Uterine PEComa: Insights from Two Case Studies.
Kabeya C; Lancelle M; Demolin G; Wattier C; Marchisello C; Buonomo A; Fonseca S
Am J Case Rep; 2024 Aug; 25():e944365. PubMed ID: 39175175
[TBL] [Abstract] [Full Text] [Related]
9. Terphenyllin induces CASP3-dependent apoptosis and pyroptosis in A375 cells through upregulation of p53.
Wu W; Wu MY; Dai T; Ke LN; Shi Y; Hu J; Wang Q
Cell Commun Signal; 2024 Aug; 22(1):409. PubMed ID: 39169379
[TBL] [Abstract] [Full Text] [Related]
10. A first-in-human phase I study of a novel MDM2/p53 inhibitor alrizomadlin in advanced solid tumors.
Zhang X; Wen X; Peng R; Pan Q; Weng D; Ma Y; Zhang Y; Yang J; Men L; Wang H; Liang E; Wang C; Yang D; Zhang L; Zhai Y
ESMO Open; 2024 Aug; 9(8):103636. PubMed ID: 39002360
[TBL] [Abstract] [Full Text] [Related]
11. Molecular Profiling and the Interaction of Somatic Mutations with Transcriptomic Profiles in Non-melanoma Skin Cancer (NMSC) in a Population Exposed to Arsenic.
Jasmine F; Argos M; Khamkevych Y; Islam T; Rakibuz-Zaman M; Shahriar M; Shea CR; Ahsan H; Kibriya MG
Cells; 2024 Jun; 13(12):. PubMed ID: 38920684
[TBL] [Abstract] [Full Text] [Related]
12. Tumor antigen PRAME is a potential therapeutic target of p53 activation in melanoma cells.
Lee YK; Heo HH; Kim N; Park UH; Youn H; Moon EY; Kim EJ; Um SJ
BMB Rep; 2024 Jun; 57(6):299-304. PubMed ID: 38835116
[TBL] [Abstract] [Full Text] [Related]
13. Co-delivery of doxorubicin-dihydroartemisinin prodrug/TEPP-46 nano-liposomes for improving antitumor and decreasing cardiotoxicity in B16-F10 tumor-bearing mice.
Jin Q; Zhou X; Niu X; Ping C; Dong X; Duan D; Wang R; Chen Y; Pan F; Yang F; Yang X; Zhang G; Wang R; Zhang S; Ren G
Colloids Surf B Biointerfaces; 2024 Sep; 241():113992. PubMed ID: 38833960
[TBL] [Abstract] [Full Text] [Related]
14. Anti-apoptotic, anti-inflammatory, and anti-melanogenic effects of the ethanol extract of Picrasma quassioides (D. Don) Benn.
Yoon JH; Kim DO; Lee S; Lee BH; Kim ES; Son YK; Kopalli SR; Lee JH; Ju Y; Lee J; Cho JY
J Ethnopharmacol; 2024 Oct; 332():118374. PubMed ID: 38789093
[TBL] [Abstract] [Full Text] [Related]
15. Oridonin, a small molecule inhibitor of cancer stem cell with potent cytotoxicity and differentiation potential.
Li Y; Xie J; Du X; Chen Y; Wang C; Liu T; Yi Z; Wang Y; Zhao M; Li X; Shi S
Eur J Pharmacol; 2024 Jul; 975():176656. PubMed ID: 38754536
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors.
Gupta V; Vashisht V; Vashisht A; Mondal AK; Alptekin A; Singh H; Kolhe R
Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674331
[TBL] [Abstract] [Full Text] [Related]
17. PERIOCULAR HIGH RISK BCCS AFTER ADDITIONAL/PARALLEL INTAKE OF TORASEMIDE, MOXONIDINE AND MIRABEGRON: IMPORTANT LINKS TO SKIN CANCER RELATED (PHOTO-) NITROSOGENESIS IN THE CONTEXT OF PHARMACO-ONCOGENESIS.
Tchernev G; Dimova D
Georgian Med News; 2024 Feb; (347):70-76. PubMed ID: 38609117
[TBL] [Abstract] [Full Text] [Related]
18. (N-NITROSO) PROPAFENONE INDUCED ADVANCED NODULAR melanoma-FIRST REPORTED CASE IN THE WORLD LITERATURE: THE INEXTRICABLE LINKS BETWEEN THE PHOTOCARCINOGENESIS, DRUG RELATED NITROSOGENESIS AND PHARMACO-ONCOGENESIS.
Tchernev G
Georgian Med News; 2024 Feb; (347):34-37. PubMed ID: 38609110
[TBL] [Abstract] [Full Text] [Related]
19. The bright side of chemistry: Exploring synthetic peptide-based anticancer vaccines.
D'Aniello A; Del Bene A; Mottola S; Mazzarella V; Cutolo R; Campagna E; Di Maro S; Messere A
J Pept Sci; 2024 Aug; 30(8):e3596. PubMed ID: 38571326
[TBL] [Abstract] [Full Text] [Related]
20. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line.
Laus AC; Gomes INF; da Silva ALV; da Silva LS; Milan MB; AparecidaTeixeira S; Martin ACBM; do Nascimento Braga Pereira L; de Carvalho CEB; Crovador CS; de Paula FE; Nascimento FC; de Freitas HT; de Lima Vazquez V; Reis RM; da Silva-Oliveira RJ
Hum Cell; 2024 Jul; 37(4):1170-1183. PubMed ID: 38565739
[TBL] [Abstract] [Full Text] [Related]
[Next]